MELISSA TUNGARE: Open Payments
NPI 1457904575 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 23 payments from 11 companies in 2025. Trend: 2023 $791 · 2024 $976 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $112 |
| HEARTFLOW, INC. | 2 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| PFIZER INC. | 2 | $47 |
| ABIOMED | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| CVRx, Inc. | 1 | $17 |
Products named: REPATHA, FFRct, JARDIANCE, VYNDAQEL, CAMZYOS, Kerendia, LEQVIO, ELIQUIS.
Industry payments across NC — which companies pay providers there.
